Welcome to the UPF Digital Repository
Browsing by Author "Lens, Sabela"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Lens, Sabela"
Now showing items 1-6 of 6
-
Senín Magan, Maria Alicia; Broquetas, Teresa; Cañete Hidalgo, Nuria; Lens, Sabela; Londoño, María-Carlota; Ferraro Rosset, Mariana Paola; Forns, Xavier; Salar Silvestre, Antonio; Carrión Rodríguez, José Antonio (Asociación Mexicana de Hepatología, 2017)The addition of the new protease inhibitors (PIs) to peg-interferon (IFN) and ribavirin (RBV), approved for chronic hepatitis C, has clearly improved sustained virological response (SVR) rates although several adverse ...
-
Lens, Sabela; Calleja, Jose Luis; Campillo, Ana; Carrión Rodríguez, José Antonio; Broquetas, Teresa; Perello, Christie; de la Revilla, Juan; Mariño, Zoe; Londoño, María-Carlota; Sánchez-Tapias, José Maria; Urbano-Ispizua, Álvaro; Forns, Xavier (Baishideng Publishing Group, 2015)elaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin. Pancytopenia due to myelotoxicity caused by these drugs may occur, but ...
-
Garriga, César; Manzanares-Laya, Sandra; García de Olalla, Patrícia; Gorrindo, Pilar; Lens, Sabela; Solà Lamoglia, Ricard; Martínez-Rebollar, María; Laguno, Montserrat; Navarro, Jordi; Torras, Xavier; Gurguí, Mercè; Barberà, María Jesús; Quer, Josep, 1965-; Masdeu, Eva; Simón, Pere; Ros, Miriam; Andrés, Anna de; Caylà i Busqueras, Joan A. (Public Library of Science (PLoS), 2017)The aims of this study were to describe the evolution of acute hepatitis C virus (HCV) infections since 2004 and to determine its associated factors. Acute HCV infections diagnosed in Barcelona from 2004 to 2015 were ...
-
Lens, Sabela; Miralpeix, Anna; Gálvez, Mont; Martró, Elisa; González, Noemi; Rodríguez-Tajes, Sergio; Mariño, Zoe; Saludes, Verónica; Reyes-Urueña, Juliana; Majó, Xavier; Colom, Joan; Forns, Xavier (Elsevier, 2022)Background & aims: Significant scale-up of treatment among people who inject drugs (PWID) is crucial to achieve WHO HCV elimination targets. We explored the impact of on-site HCV diagnosis and treatment on PWID in an ...
-
Gambato, Martina; Caro-Pérez, Noelia; González, Patricia; Cañete Hidalgo, Nuria; Mariño, Zoe; Lens, Sabela; Bonacci, Martín; Bartres, Concepció; Sánchez-Tapias, José-María; Carrión Rodríguez, José Antonio; Forns, Xavier; Juan, Manel; Pérez-del-Pulgar, Sofía; Londoño, María-Carlota (Public Library of Science (PLoS), 2016)Real-life data showed an increased incidence of bacterial infections in patients with advanced liver disease receiving a protease inhibitor (PI)-containing antiviral regimen against hepatitis C (HCV). However, the causes ...
-
Forns, Xavier; Colom, Joan; García-Retortillo, Montserrat; Quer, Joan Carles; Lens, Sabela; Martró, Elisa; Domínguez-Hernández, Raquel; Casado, Miguel Angel; Buti, María (Wiley, 2022)According to WHO goals, the elimination of Hepatitis C Virus (HCV) by 2030 requires enhancing and simplifying HCV testing. Our aim was to create a model to assess and compare different strategies for HCV testing, linkage ...
Now showing items 1-6 of 6
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00